✦ LIBER ✦

Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches: Results of an Open-Label Extension Trial in Adolescents

✍ Scribed by George Apostol; Ann Pakalnis; Genevieve A. Laforet; Weining Z. Robieson; Evelyn Olson; Walid M. Abi-Saab; Mario Saltarelli

Book ID: 109100451
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 80 KB
Volume: 49
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.2008.01299.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Divalproex Sodium Extended-Release for t

Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study

✍ George Apostol; Donald W. Lewis; Genevieve A. Laforet; Weining Z. Robieson; Juli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

An open-label pilot study on the efficac

An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine

✍ Virgilio Gallai; Andrea Alberti; Cristiana Rossi; Francesca Coppola; Beatrice Ga 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 92 KB

Effectiveness and tolerability of paroxe

Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea

✍ Chi-Un Pae; Won-Myong Bahk; Duk-In Jon; Sang-Yeol Lee; Bo-Hyun Yoon; Kyung Joon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled

Long-term efficacy and safety of etanerc

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial

✍ Daniel J. Lovell; Edward H. Giannini; Andreas Reiff; Olcay Y. Jones; Rayfel Schn 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Efficacy of adalimumab in the treatment

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

✍ Hildrun Haibel; Martin Rudwaleit; Joachim Listing; Frank Heldmann; Robert L. Won 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 3 views